US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports
ReutersMar 11, 2026 9:14 AM
March 11 (Reuters) - A key federal vaccine advisory panel has abandoned an attack on COVID mRNA vaccines, the Washington Post reported on Wednesday, citing two people familiar with the matter.
Some of Health and Human Services Secretary Robert F. Kennedy Jr.'s vaccine advisers had been seeking to potentially stop recommending mRNA shots, but that plan is no longer moving forward, the report said.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Bitcoin Price Analysis: BTC Eyes $72K Breakout Amid Mideast Supply Shocks and Short Squeeze Risk
BTC faces a critical $72K resistance amid Middle East supply shocks and a $4.3B short squeeze risk. Explore the latest btc price trends, institutional ETF outflows, and the impact of the upcoming "Clarity Act" on bitcoin’s market forecast.TradingKey
3 hours ago
Gold Stalls at $5,400: BlackRock iShares Strategist Insists the Bull Cycle Is Just Getting Started
Easing tensions in the Middle East and a strengthening US dollar have caused gold prices to stagnate, but bullish sentiment on Wall Street remains elevated.TradingKey
8 hours ago
CRCL Beyond $100: Decoding the Forces Behind Circle’s 100% Rally and the Quest for $300
Circle leads crypto stocks, surging 107% over the past month to $110 and entering a critical zone.TradingKey
Tue, Mar 10
Micron vs. Samsung vs. SK Hynix: Is MU Stock the Best Memory Stock for 2026?
TradingKey - Relying on strong AI demand, more memory per system, and sluggish supply response, 2026 will be the memory cycle. Micron Technology (MU) is now in an excellent competitive position today with HBM3E and looking to ramp HBM4E into Nvidia’s Vera Rubin platforms in the second half of 2026.TradingKey
Tue, Mar 10
